Zita-Met 1000mg/20mg Tablet ER

This fixed-dose combination is indicated for the management of type 2 diabetes mellitus in patients inadequately controlled by diet, exercise, and monotherapy. The extended-release formulation ensures a sustained plasma concentration, improving patient compliance and minimizing gastrointestinal side effects commonly associated with immediate-release metformin. Zita-Met should be used as part of a comprehensive diabetes management plan including diet and exercise.

It is contraindicated in patients with renal impairment, metabolic acidosis, or hypersensitivity to its components. Regular monitoring of renal function and glycemic parameters is recommended during therapy. Dose adjustments may be necessary based on clinical response and tolerability. This combination offers a synergistic approach to glycemic control by targeting multiple pathophysiological defects in type 2 diabetes.